Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2012; 18(48): 7357-7361
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7357
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7357
Table 2 Comparison of pepsinogen levels between gastric cancer, gastric atrophy and control groups
| Gastric cancer group | Gastric atrophy group | Control group | P value (cancer vs control) | P value (atrophy vs control) | |
| PGI(μg/L) | 93.2 (49.8-147.3) | 64.0 (52.3-75.3) | 92.6 (75.0-116.1) | 0.537 | < 0.001 |
| PG II (μg/L) | 15.9 (9.0-28.0) | 13.9 (11.9-16.9) | 11.5 (7.1-18.4) | < 0.001 | < 0.001 |
| PGI/PGII | 5.4 (3.5-8.1) | 4.6 (3.6-5.3) | 8.4 (6.1-11.1) | < 0.001 | < 0.001 |
- Citation: Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J, Jiang J. Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol 2012; 18(48): 7357-7361
- URL: https://www.wjgnet.com/1007-9327/full/v18/i48/7357.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i48.7357